Lydia Foster to Risk Assessment
This is a "connection" page, showing publications Lydia Foster has written about Risk Assessment.
Connection Strength
0.048
-
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019 05; 18(5):428-438.
Score: 0.027
-
Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016 03 03; 17(1):120.
Score: 0.021